These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34268521)

  • 21. Seroprevalence of SARS-CoV-2 among high-risk healthcare workers in a MERS-CoV endemic area.
    Alroqi F; Masuadi E; Alabdan L; Nogoud M; Aljedaie M; Abu-Jaffal AS; Barhoumi T; Almasoud A; Alharbi NK; Alsaedi A; Khan M; Arabi YM; Nasr A
    J Infect Public Health; 2021 Sep; 14(9):1268-1273. PubMed ID: 34479078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
    Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
    Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission.
    Rivett L; Sridhar S; Sparkes D; Routledge M; Jones NK; Forrest S; Young J; Pereira-Dias J; Hamilton WL; Ferris M; Torok ME; Meredith L; ; Curran MD; Fuller S; Chaudhry A; Shaw A; Samworth RJ; Bradley JR; Dougan G; Smith KG; Lehner PJ; Matheson NJ; Wright G; Goodfellow IG; Baker S; Weekes MP
    Elife; 2020 May; 9():. PubMed ID: 32392129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia.
    Alharbi NK; Alghnam S; Algaissi A; Albalawi H; Alenazi MW; Albargawi AM; Alharbi AG; Alhazmi A; Al Qarni A; Alfarhan A; Zowawi HM; Alhatmi H; Alghamdi J; Alroqi F; Batarfi K; Arabi YM; Hashem AM; Bosaeed M; Aldibasi O
    J Infect Public Health; 2021 Jul; 14(7):832-838. PubMed ID: 34118732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.
    Galanis P; Vraka I; Fragkou D; Bilali A; Kaitelidou D
    J Hosp Infect; 2021 Feb; 108():120-134. PubMed ID: 33212126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Longitudinal Analysis on the Anti-SARS-CoV-2 Antibodies among Healthcare Workers in Poland-Before and after BNT126b2 mRNA COVID-19 Vaccination.
    Lorent D; Nowak R; Luwański D; Pisarska-Krawczyk M; Figlerowicz M; Zmora P
    Vaccines (Basel); 2022 Sep; 10(10):. PubMed ID: 36298441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroprevalence study of SARS-CoV-2 antibodies in healthcare workers following the first wave of the COVID-19 pandemic in a tertiary-level hospital in the south of Ireland.
    Faller E; Wyse A; Barry R; Conlon K; Everard C; Finnegan P; Foran C; Herlihy E; Kerr G; Lapthorne S; McGreal-Bellone A; Morrissey E; O'Sullivan D; O'Sullivan G; Eustace JA; Spillane D; Dempsey C; Benson J; Prentice M; Gallagher J; MacSharry J; Fanning LJ; O'Riordan S; Horgan M; Sadlier C
    BMJ Open; 2021 Jun; 11(6):e051415. PubMed ID: 34103324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for SARS-CoV-2 seropositivity in a health care worker population during the early pandemic.
    Schubl SD; Figueroa C; Palma AM; de Assis RR; Jain A; Nakajima R; Jasinskas A; Brabender D; Hosseinian S; Naaseh A; Hernandez Dominguez O; Runge A; Skochko S; Chinn J; Kelsey AJ; Lai KT; Zhao W; Horvath P; Tifrea D; Grigorian A; Gonzales A; Adelsohn S; Zaldivar F; Edwards R; Amin AN; Stamos MJ; Barie PS; Felgner PL; Khan S
    BMC Infect Dis; 2023 May; 23(1):330. PubMed ID: 37194021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers.
    Gelanew T; Seyoum B; Mulu A; Mihret A; Abebe M; Wassie L; Gelaw B; Sorsa A; Merid Y; Muchie Y; Teklemariam Z; Tesfaye B; Osman M; Jebessa G; Atinafu A; Hailu T; Habte A; Kenea D; Gadisa A; Admasu D; Tesfaye E; Bates TA; Bulcha JT; Tschopp R; Tsehay D; Mullholand K; Howe R; Genetu A; Tafesse FG; Abdissa A
    BMC Infect Dis; 2022 Mar; 22(1):261. PubMed ID: 35296265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroprevalence of SARS-CoV-2 Antibodies and Associated Factors in Healthcare Workers before the Era of Vaccination at a Tertiary Care Hospital in Turkey.
    Sonmezer MC; Erul E; Sahin TK; Rudvan Al I; Cosgun Y; Korukluoglu G; Zengin H; Telli Dizman G; Inkaya AC; Unal S
    Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence and factors associated with SARS-CoV-2 infection among healthcare workers: cross-sectional study.
    Taher WT; Bawazir AA; Sallam TA; Alsurimi K
    BMC Infect Dis; 2023 Nov; 23(1):761. PubMed ID: 37932664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 seroprevalence among 7950 healthcare workers in the Region of Southern Denmark.
    von Huth S; Lillevang ST; Røge BT; Madsen JS; Mogensen CB; Coia JE; Möller S; Justesen US; Johansen IS
    Int J Infect Dis; 2021 Nov; 112():96-102. PubMed ID: 34534698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enzyme-Linked Immunosorbent Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) IgM/IgA and IgG Antibodies Among Healthcare Workers.
    Alharbi SA; Almutairi AZ; Jan AA; Alkhalify AM
    Cureus; 2020 Sep; 12(9):e10285. PubMed ID: 33047077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 IgG response in symptomatic and asymptomatic COVID-19-infected healthcare workers.
    Cordova E; Bacelar B; Nieto F; Garibaldi F; Aguirre V; Machuca M; Badia M; Rodriguez C
    Occup Med (Lond); 2021 Aug; 71(4-5):215-218. PubMed ID: 34008016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.
    Iruretagoyena M; Vial MR; Spencer-Sandino M; Gaete P; Peters A; Delgado I; Perez I; Calderon C; Porte L; Legarraga P; Anderson A; Aguilera X; Vial P; Weitzel T; Munita JM
    BMC Infect Dis; 2021 May; 21(1):478. PubMed ID: 34039287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [SARS-CoV-2 Seroprevalence Among Healthcare Workers: Retrospective Analysis of the Data From A University Hospital in Turkey].
    Özdemir A; Demir Çuha M; Telli Dizman G; Alp A; Metan G; Şener B
    Mikrobiyol Bul; 2021 Apr; 55(2):223-232. PubMed ID: 33882653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Follow-up SARS-CoV-2 serological study of a health care worker cohort following COVID-19 booster vaccination.
    Hönning A; Tomczyk S; Hermes J; Grossegesse M; Hofmann N; Michel J; Neumann M; Nitsche A; Hoppe B; Eckmanns T; Schmidt-Traub H; Zappel K
    BMC Infect Dis; 2024 Apr; 24(1):436. PubMed ID: 38658874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.
    Musa S; Abdel Alem S; Amer K; Elnagdy T; Hassan WA; Ali MA; Gaber Y; Badary HA; Tantawi O; Abdelmoniem R; Radwan A; Yousof H; Shawky S; Talaat H; Fouad R; Kassem AM
    J Infect Public Health; 2021 Oct; 14(10):1466-1473. PubMed ID: 34175238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers.
    Bansal A; Trieu MC; Mohn KGI; Madsen A; Olofsson JS; Sandnes HH; Sævik M; Søyland H; Hansen L; Onyango TB; Tøndel C; Brokstad KA; ; Syre H; Riis ÅG; Langeland N; Cox RJ
    Front Public Health; 2023; 11():1164326. PubMed ID: 37546332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response.
    Shields AM; Faustini SE; Perez-Toledo M; Jossi S; Allen JD; Al-Taei S; Backhouse C; Dunbar L; Ebanks D; Emmanuel B; Faniyi AA; Garvey MI; Grinbergs A; McGinnell G; O'Neill J; Watanabe Y; Crispin M; Wraith DC; Cunningham AF; Drayson MT; Richter AG
    medRxiv; 2020 Nov; ():. PubMed ID: 33236029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.